The China Periodontal Disease Treatment Market was valued at $113.02 Million in 2024 and projected to reach to $162.02 Million by 2029, representing a compound annual growth rate of 6.2%. China's periodontal disease treatment market is positioned for sustained growth through 2029, supported by a 6.2% CAGR that outpaces the global average of 5.9%.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
China's periodontal disease treatment market reached USD 113.02 million in 2024 and is expected to grow to USD 162.02 million by 2029, demonstrating strong market expansion driven by healthcare investments and rising dental awareness.
China's rapidly aging demographic is significantly increasing periodontal disease prevalence, creating sustained demand for treatment solutions and preventive care services across urban and rural healthcare facilities.
Expanding access to modern periodontal therapies, including laser treatments and minimally invasive procedures, is transforming China's dental care landscape and improving patient outcomes in major metropolitan areas.
Growing consumer education campaigns and government health initiatives in China are elevating oral health consciousness, driving earlier disease detection and increased treatment-seeking behavior among the population.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
The global periodontal disease treatment market, valued at USD 2.71 billion in 2025, stood at USD 2.86 billion in 2026 and is projected to advance at a resilient CAGR of 6.2% from 2026 to 2031, culminating in a forecasted valuation of USD 3.86 billion by the end of the period. Poor oral hygiene practices, change in lifestyle, smoking habits, and the geriatric population are some of the major reasons contributing to increasing cases of periodontal diseases, hence driving the market. Greater awareness of oral health and an intensifying relationship between oral health and systemic health have encouraged many patients to visit dental health services for prevention and treatment purposes. Minimally invasive surgical treatments, laser treatment, and advanced diagnostic treatment options have facilitated the effective management of periodontal diseases; treatment has become easier and painless, thus reducing the stress associated with treatment. In addition, the growth of private dental practices and dental departments within hospitals, rising affluence, and increased emphasis on regular dental health visits will continue to drive the demand for periodontal disease treatment.
The global periodontal disease treatment market has been witnessing significant growth, mainly as a result of a higher level of awareness about oral health, the increased occurrence of periodontal diseases, and the availability of advanced dental care solutions. Some of the key factors behind the increased incidence of gum diseases are the rising elderly population, growing number of smokers and diabetics, and the adoption of different lifestyle habits, which in turn have led to a rising demand for periodontal treatments, both preventive and therapeutic. The market is also benefiting from innovations in treatment methods, such as minimally invasive surgical procedures, the use of lasers, and the creation of new biomaterials and regenerative products.
The market for periodontal disease treatment is undergoing a massive change because of the trends and disruptions that are impacting the needs of the dental care providers and patients. A move away from the traditional consumables and medication-based revenue streams to more advanced periodontal technology, minimally invasive surgery, and digital diagnostic capabilities indicates a higher demand for early intervention, precise treatment, and chronic disease management. Hospitals, dental practices, group practices, and Dental Service Organizations (DSOs) are realizing the need for greater clinical efficiency, better workflow, minimal pain and discomfort for patients, and alignment with the increasing dental care standards. These forces are driving the need for innovative technologies and maintenance-based treatment modalities, resulting in overall superior clinical outcomes, patient satisfaction, operational efficiencies, and growth in the periodontal disease treatment market.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Growth in the incidence of oral health problems is the primary factor driving the periodontal disease treatment market. The risk of periodontal diseases has been significantly elevated due to the mixture of different factors such as bad oral habits, high consumption of sugar, smoking, stress, diabetes, and aging populations. Should these diseases go untreated, the patients will be in an ever-increasing need of preventive and therapeutic periodontal treatments. The increase in oral health problems has also resulted in higher awareness among patients and doctors, which in turn leads to early diagnosis and prompt treatment, and thus, the market of periodontal disease treatment keeps expanding.
High cost of advanced therapies, as well as poor reimbursement rates for dental procedures, are some of the key factors inhibiting the growth of the periodontal disease treatment industry. Advanced periodontal therapy, such as that involving lasers, regenerative procedures, or complex surgeries, may involve expensive infrastructure. In some regions, many dental procedures may not be covered or, in some cases, may be completely excluded from standard health insurance plans. As such, many patients may have to pay out of their pockets, which may act as a deterring factor in seeking timely or advanced periodontal treatment.
The increasing presence of Dental Service Organizations (DSOs) represents an important opportunity in the periodontal disease treatment market with respect to the reformation of dental care delivery. DSOs assist dental practices by providing organization and support in relation to purchasing, technology implementation, and administration, thereby ensuring that practices function in a more effective and efficient manner and are oriented towards better patient care. DSOs with increasing presence enable greater standardization of periodontal treatment approaches, advanced technological implementation in practices, and better access to specialized care for periodontitis in various locations. In addition to this, DSOs increase patient access due to improved recognition and simpler pricing structures, along with greater recognition by various insurance providers, thereby promoting larger volumes of treatment.
The challenge of a lack of skilled dental practitioners affects the development of the periodontal disease treatment market. Both conventional and advanced treatments require specialized skills that are not available on a similar level in all regions across the world. For instance, in some developing countries, it may be hard to access periodontists and skilled dental practitioners due to limited numbers of skilled professionals, resulting in a lack of quick and effective treatment for patients with periodontal disease. This hampers the development of the periodontal disease treatment market and slows its overall growth due to a shortage of skilled dental practitioners.
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
|
|
The company manufactures resorbable or non-resorbable barrier membranes, which can be used for guided tissue regeneration or guided bone regeneration. This is done by acting as a barrier between the soft tissue and the bone, allowing cells to repopulate the area selectively. This process helps to regenerate the periodontal ligaments, cementum, and alveolar bone. | Dentsply Sirona membranes improve clinical results by facilitating predictable tissue regeneration, as well as providing better wound stability. Biocompatibility, as well as the ability to be resorbed, reduces the reliance on further surgical interventions, enhancing the efficiency of the healing process while allowing the achievement of periodontal stability. |
|
|
The company has specialized in the delivery of regenerative periodontal products, biomaterials, and adjunctive regenerative devices that are used in treating periodontal defects caused by advanced gum diseases. These are usually applied in periodontic flap surgeries to help in the regeneration of bone and tissue in the affected areas and to support the tooth structure. | The regenerative solutions developed by Envista optimize predictability and promote rapid healing of tissues by improving biological integration in the defect area. The products help healthcare professionals efficiently tackle complex cases related to periodontal diseases and optimize tooth retention, thus ensuring enhanced patient satisfaction and efficiency in practices. |
|
|
Institut Straumann Holdings AG has advanced tissue-regenerative materials such as biologics and biomaterials for use in periodontal regeneration. These materials are useful in regenerating periodontal structures by promoting the growth of natural tissues in the case of severe periodontitis and/or peri-implant defects. | Straumann's tissue regenerative materials enhance regenerative outcomes by encouraging bodily healing and facilitating soft and hard tissue integration. The clinically proven efficacy of Straumann's materials shortens healing time, improves long-term stability of periodontal conditions, and makes minimally invasive surgeries possible, which benefits dentists and patients in many ways. |
|
|
Henry Schein, Inc. offers various types of bone grafting materials that are employed in the treatment of periodontal disease for the regeneration of alveolar bone damaged because of chronic periodontitis. These products find their applications in the treatment of periodontal and implant-related disorders. | Henry Schein's bone grafting products support reliable bone regeneration and strengthen the jaw. This extensive product line allows dental professionals to select the appropriate products to address bone defects, thereby improving ease of treatment, outcomes, and overall periodontal health. |
|
|
Nakanishi Inc. offers advanced oral care tools, such as high-speed handpieces and professional oral care tools, which are employed for periodontal therapy procedures like scaling, root planing, as well as plaque removal. | The company's oral hygiene products increase the efficiency of treatments through their ability to remove plaque and calculus without significant discomfort to the patient. These products have been designed for efficiency and functionality, which will increase clinical efficiency and the management of periodontal diseases through improved hygiene practices. |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
The periodontal disease treatment market includes several manufacturers, distributors, end users, and regulatory bodies, which operate together to develop, distribute, and allow for the adoption of periodontal treatment-related products. Major manufacturers such as Nakanishi, Yoshida, Ultradent Products, Geistlich Biomaterials, and Henry Schein Inc. offer high-end dental equipment, biomaterials, and surgical instruments. The distribution chain includes distributors such as Henry Schein Inc., BIOLASE Inc., MORITA, Regenity Ltd., and AMD LASERS. End users of these products include major health organizations and dental practices such as AdventHealth, Mount Sinai, Mayo Clinic, Cleveland Clinic, Johns Hopkins Medicine, and NHS Barts Health Hospitals. Regulatory authorities in this market, such as the US FDA, the UK EMA, and India's CDSCO, ensure that the quality of the product, its safety, effectiveness, and adherence to international standards are ensured; therefore, this market is also well-structured.
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Equipment currently holds the largest market share, as it is a requirement in the diagnosis, prevention, as well as treatment of periodontal diseases. Equipment like ultrasonic scalers, lasers, surgery items, imaging solutions, as well as treatment chairs, is commonly required in non-surgical as well as surgical periodontal treatment, which ensures steady sales of such items. Technological advancements related to solutions such as lasers, minimally invasive surgery, and computerized diagnostics have also aided in cementing this particular market share. Further, advancements related to steady improvements of such solutions to reduce treatment time, along with increasing usage of periodontal solutions, have aided in increasing this particular.
Gingivitis holds the largest share mainly because of its high prevalence, being the most widely reported disorder across all age groups. Being the first and most widespread stage of periodontal disease, gingivitis is generally noticed upon routine dental examinations, and this leads to a great number of people going for treatment. Since the disease can be reversed if treatment is given on time, there is a strong demand for preventive and non-surgical dental care procedures such as professional dental cleaning, scaling, and oral hygiene maintenance. More and more people are becoming aware of oral health and preventive dental care, which has made gingivitis the dominant disease type in the periodontal disease treatment market.
Non-surgical treatment represents the highest segment of the market, by treatment type. It is widely used as a primary intervention for the management of periodontal conditions, especially gingivitis and early-stage periodontitis. On the other hand, minimally invasive and more affordable procedures such as scaling and root planing, professional dental cleaning, and antimicrobial therapy represent a preferable option for patients and dental professionals. Such treatments are usually performed on the occasion of a routine dental check and do not require complicated surgical infrastructure, which justifies their broad dispersal across dental clinics. The rising emphasis on prevention, early diagnosis, and continuous maintenance therapy further supports the leading position of non-surgical treatment within the periodontal disease treatment market.
Hospitals hold a considerable share of the periodontal disease treatment end-user market. They can offer comprehensive periodontal and dental care in the same environment. They have the latest diagnostic imaging technology, top-notch surgical facilities, and expert dental professionals, enabling them to not only provide general treatments but also perform complex periodontal surgeries. Moreover, hospitals have a wide patient base, including advanced periodontal cases or patients with other health conditions who need coordinated, multidisciplinary care. Besides, the use of advanced treatment methods, compliance with strict infection control protocols, and higher patient trust in hospital-based services are some of the factors that have helped hospitals to maintain the dominant position in the periodontal disease treatment market.
The Middle East and Africa (MEA) region is being recognized as the fastest-growing market for periodontal disease treatment as a result of demographic, epidemiological, and healthcare system factors. Due to low levels of oral hygiene awareness, high tobacco use, rising diabetes rates, and changing eating habits, especially in urban areas, the region is experiencing an increase in the prevalence of periodontal diseases. Rapid population growth and a large number of untreated patients also lead to the increased demand for periodontal therapies. Besides that, local governments in the Gulf Cooperation Council (GCC) countries and some African nations are raising their healthcare budgets and modernizing their dental infrastructures, which is facilitating access to advanced periodontal treatments such as scaling and root planing, laser therapy, and regenerative procedures. The growth of dental tourism in the UAE and Turkey, as well as the development of private dental clinics and specialty centers, is contributing to the market expansion.

In the periodontal disease treatment market matrix, Dentsply Sirona (US) (Star) and Henry Schein, Inc. (US) (Star) lead with their unmatched global presence, strong brand recognition, and comprehensive portfolios of periodontal disease treatment. Yoshida Dental MFG. Co., Ltd. (Japan) (Emerging Leader) is rapidly gaining traction with its versatile medical gas and equipment products for therapeutic and diagnostic applications.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
| REPORT METRIC | DETAILS |
|---|---|
| Market Size in 2025 (Value) | USD 2.71 Billion |
| Market Forecast in 2031 (Value) | USD 3.86 Billion |
| Growth Rate | CAGR of 6.2% from 2026-2031 |
| Years Considered | 2025-2031 |
| Base Year | 2025 |
| Forecast Period | 2026-2031 |
| Units Considered | Value (USD Million/Billion), Volume (Thousands Units) |
| Report Coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered |
|
| Regions Covered | North America, Europe, Asia Pacific, Latin America, Middle East & Africa, GCC Countries |
| Related Segment & Geographic Reports |
US Periodontal Disease Treatment Market APAC Periodontal Disease Treatment Market |

We have successfully delivered the following deep-dive customizations:
| CLIENT REQUEST | CUSTOMIZATION DELIVERED | VALUE ADDS |
|---|---|---|
| Volume Analysis | Market assessment by volume (units) for dental equipment used in digital dentures ecosystem |
|
| Product Analysis | Further breakdown of other applications in the market | Insights on other applications involved in the market |
| Company Information |
|
Insights on market share analysis by country |
| Geographic Analysis |
|
Country-level demand mapping for new product launches and localization strategy planning |
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | AGGRESSIVE PERIODONTITIS (Disease) |
| Forecast Period | 2024–2029 |
| Growth Rate | CAGR of 5.9% from 2024 to 2029 |
| Largest Segment | NON-SURGICAL TREATMENT (Treatment) |
| Market Size Base Year (Billions) | ~USD 2.57 (2024) |
| Revenue Forecast (Billions) | ~USD 3.43 (2029) |
| Segments Covered | Product, Disease, Type, Treatment |
4 segment dimensions are covered across the global market.
| Segment | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|---|
| ACADEMIC & RESEARCH INSTITUTES | 25 | 26.1 | 27.3 | 28.5 | 29.8 | 31.2 | 32.8 | 34.5 | 36.3 | 4.9 |
| DSOS & INDEPENDENT CLINICS | 67.4 | 71.1 | 75 | 79.2 | 83.6 | 88.4 | 93.7 | 99.4 | 105.6 | 5.9 |
| HOSPITALS | 106.5 | 114.8 | 123.8 | 133.6 | 144.2 | 155.8 | 168.9 | 183.2 | 199 | 8.2 |
| TOTAL | 198.8 | 212 | 226.1 | 241.2 | 257.6 | 275.5 | 295.4 | 317.1 | 340.9 | 7.1 |
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| DENTSPLY SIRONA | United States | Public Company | Connected Technology Solutions,Essential Dental Solutions,Orthodontic and Implant Solutions, |
| ENVISTA HOLDINGS CORPORATION | United States | Public Company | Specialty Products & Technologies – Implants & Biomaterials,Specialty Products & Technologies – Orthodontics & Clear Aligners,Equipment & Consumables – Imaging, Software & Visualization, |
| HENRY SCHEIN, INC. | United States | Public Company | Global Distribution and Value-Added Services,Global Specialty Products,Global Technology, |
| BIOLASE, INC. | United States | Public Company | Waterlase all-tissue systems,Diode soft-tissue systems,Consumables, fibers, and handpieces, |
| NAKANISHI INC. | Japan | Public Company | Dental handpieces (air turbines, contra-angles, micromotors),Surgical and mobile dentistry systems,Dental lab, hygiene, and maintenance products, |
| A-DEC INC. | Switzerland | Public Company | Flexible placement (temporary staffing and contracting),Permanent placement and career transition,Outsourcing and engineering consulting, |
DENTSPLY SIRONA is a United States-based public company founded in 1877 with 14,000 employees. The company operates in the dental industry.
ENVISTA HOLDINGS CORPORATION is a United States-based public company founded in 2018 with 12,000 employees. The company operates in the dental industry.
HENRY SCHEIN, INC. is a United States-based public company founded in 1932 with 25,000 employees. The company operates in the dental industry.
BIOLASE, INC. is a United States-based public company founded in 1984 with 157 employees. The company operates in the dental industry.
NAKANISHI INC. is a Japan-based public company founded in 1930 with 2,204 employees. The company operates in the dental industry.
A-DEC INC. is a Switzerland-based public company founded in 1957 with 33,569 employees. The company operates in the dental industry.
China's periodontal disease treatment market was valued at USD 113.02 million in 2024.
China's periodontal disease treatment market is projected to reach USD 162.02 million by 2029.
China's periodontal disease treatment market is expected to grow at a compound annual growth rate (CAGR) of 6.2% from 2024 to 2029.
Key growth drivers in China include rising oral health awareness, increasing prevalence among the aging population, expansion of private dental clinics, government health initiatives, and adoption of advanced treatment technologies.
China is seeing increased adoption of laser-assisted therapies, guided tissue regeneration, digital diagnostic tools, and implant-supported solutions for periodontal disease treatment.
Full forecast, segment splits, and company analysis for all Periodontal Disease Treatment Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report